MECOM and head and neck squamous cell carcinoma: In principle, it could be due to the fact that shEVI1-1, but not shEVI1-2, also targets a poorly characterized EVI1 splice variant termed EVI1Δ324, which is usually expressed along with full-length EVI1 [35] and was also present in the HNSCC cell lines investigated (Figure S1A).